Siemens CEO Says Germany Has Big Industrial Data Set for AI Push
'We are sitting on a massive amount of data,' Busch said Monday during a Bloomberg TV interview. 'This is one of the most industrialized economies in the world, and again, small and medium sized enterprises, large ones, they're creating data from their buildings, their manufacturing sites, their engineering.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
2 minutes ago
- The Hill
Is Giorgia Meloni the ‘Iron Lady' for the Trump era?
In the twilight of the Cold War, the West's resurgence was defined by the extraordinary partnership between President Ronald Reagan, Prime Minister Margaret Thatcher and Pope John Paul II. Their alliance — grounded in a shared vision of political freedom, faith and economic liberty — reshaped the world. Today, as President Trump works to remake America's place in the world and Pope Leo launches his papacy with strong calls for human dignity in the AI era, one wonders who in Europe can rise to the moment as Thatcher once did. The answer, increasingly, seems to be Italian Prime Minister Giorgia Meloni. The 2020s are witnessing the rise of a new transatlantic alliance in which Meloni is poised to play the pivotal European role. As the continent's political center struggles with fragmentation and fatigue, Meloni has emerged not just as a survivor, but as the most powerful person in Europe, a bridge between Washington and Brussels and the architect of a new conservative order. Why does Meloni matter now? Recall what made the Thatcher-Reagan partnership so exceptional. Thatcher was not Reagan's sidekick but his intellectual peer and sometimes his challenger. Both leaders were outsiders who stormed the establishment, preaching the virtues of free enterprise and national renewal. Their rapport was legendary, rooted in mutual respect, frequent communication and a willingness to push each other toward bolder action. Thatcher's influence was felt not only in her steadfast support for Reagan's confrontation with the Soviet Union but also in her ability to shape his thinking. Their partnership was not frictionless; disagreements over the Falklands, Grenada and economic policy occasionally flared, but their unity was a force multiplier for the Western world. Fast forward to 2025, and Europe is searching for a new Thatcher — a leader with the vision, resolve and political skill to partner with an assertive America. Enter Meloni, Italy's first female prime minister. Meloni's rise is Thatcherite in its improbability. Once dismissed as a neo-fascist firebrand, she has transformed her Brothers of Italy party from the fringes to the mainstream, presiding over a stable government in a country known for its political chaos. Her coalition dominates Italian politics, and her approval ratings have remained robust even as she pursues controversial reforms. What sets Meloni apart, however, is her growing stature on the world stage. She has become the European leader most closely aligned with Trump, earning his praise and trust. She was the only EU head of government invited to Trump's 2025 inauguration — a symbolic nod to her emerging role as the continent's conservative standard-bearer. The parallels with the Reagan-Thatcher era are striking. Like Thatcher, Meloni is a conviction politician with a talent for coalition-building and a knack for bending events to her will. She has used her position to shift the European debate on migration, security and sovereignty — championing policies that have been adopted, in some form, by Brussels and emulated by other European leaders. Meloni's diplomatic skills have also been on display in her dealings with Washington and Brussels. She has managed to maintain Italy's support for Ukraine and NATO while also cultivating ties with Trump's inner circle and other right-wing populists. Her ability to bridge the gap between an increasingly nationalist America and a fragmented Europe is reminiscent of Thatcher's role as the indispensable transatlantic interlocutor. Of course, the analogy is not perfect. Meloni's Italy is not the U.K. of the 1980s, and today's geopolitical landscape is more multipolar. Thatcher's Britain was a nuclear power and America's closest ally. Meloni's Italy, while influential, does not command the same global clout. Europe today is more fractured, and the threats it faces — migration, energy insecurity, technological disruption — are different from the existential menace of Soviet communism. Yet Meloni's impact is undeniable. She has demonstrated that European leaders can still shape the global agenda, provided they combine ideological clarity with political pragmatism. Like Thatcher, Meloni is willing to challenge orthodoxy and take risks, even at the cost of controversy. As Trump seeks to recast America's role in the world, he needs a European partner who is more than a cheerleader — someone who can match him in vision and tenacity. Meloni, with her blend of conviction, charisma and strategic sense, is uniquely positioned to play that part. The Reagan-Thatcher-John Paul II alliance changed the course of history. Whether Meloni and Trump can forge a partnership of similar consequence remains to be seen. But as Europe's new power broker, Meloni has already shown she is ready to step onto the world stage — and perhaps, like Thatcher before her, help shape the destiny of the West.
USA Today
2 minutes ago
- USA Today
TACO or tariffs? Trump's big trade deadline is coming. Here's what to expect
If Trump holds firm to his third deadline, a slew of countries will face steep levies, including a 50% tariff on imports from Brazil and a 30% tariff on the European Union. Standing in the Rose Garden and holding a giant chart, President Donald Trump, who likes to call himself 'Tariff Man' showed off the 'reciprocal' tariffs he was planning to levy on dozens of countries. That was April 2, christened 'Liberation Day' by Trump. Almost four months and two extensions later, a new Aug. 1 deadline is looming. A slew of countries will face steep tariffs − including a 50% tariff on imports from Brazil and a 30% tariff on the European Union. A baseline tariff of 10% remains for all countries. 'We'll have a straight, simple tariff of anywhere between 15% and 50%," Trump said during an AI summit in Washington, on July 23. "We have 50 (percent) because we haven't been getting along with those countries too well." Are new tariffs really coming? Will there be another extension? Trump has said no. But Treasury Secretary Scott Bessent recently left the door open for a third reprieve. The first deadline, on April 9, was paused for 90 days − until July 9 − after it caused significant turbulence in the financial markets and economists warned of a potential recession. "I thought that people were jumping a little bit out of line," Trump said on April 9. 'They were getting yippy, you know. They were getting a little bit yippy, a little bit afraid." Trump's shifting on the deadlines also gave birth to an acronym: TACO, for Trump Always Chickens Out, mocking his on-again-off-again tariff policies. A pause – then a tariff storm On July 7, two days before the new tariffs were to go into effect, Trump extended the deadline to Aug. 1, saying several countries were negotiating deals. Trump also began sending letters on July 7 to countries letting them know of the new, updated tariffs that would be imposed on them. The first batch of 14 letters to countries including South Africa and Malaysia also made clear that if they retaliated against the United States with their own tariffs, their target tariffs would go even higher. On July 9, he sent tariff letters to another eight countries, including Brazil. So far, the United States has sent 25 tariff letters, White House Press Secretary Karoline Leavitt said on July 23. What trade deals have been struck so far? While the U.K. was the first country to reach a trade agreement with the United States, the latest and the most significant deal so far has been with Japan, Washington's fifth-largest trading partner. Other countries with whom Trump announced deals in recent months include Indonesia, Vietnam and the Philippines. On July 22, Trump announced a 'massive deal' with Japan under which the United States would impose a 15% tariff on Japanese imports. Trump had previously threatened a 24% tariff on Japan. He also wrote said Japan would invest $550 billion in the United States and that the United States would receive 90% of the profits, without offering any details. His announcement also said Japan had agreed to open up to imports of vehicles, rice and other agricultural products from the United States. Of the five countries that the United States has struck trade deals with, it only runs a trade surplus with the U.K. TACO time? On July 21, in an interview with CNBC, Bessent was noncommittal on whether there could be an extension for countries negotiating in good faith. 'We'll see what the president wants to do,' Bessent said. He added that reverting to the steep tariffs that were first proposed after the deadline might force countries to come up favorable terms. 'But again, if we somehow boomerang back ... I would think that a higher tariff level will put more pressure on those countries to come with better agreements,' said Bessent. Meanwhile Trump has repeatedly said there will be 'no change' in the deadline. 'In other words, all money will be due and payable starting AUGUST 1, 2025 − No extensions will be granted,' he wrote on Truth Social on July 8. What's happening with tariffs on Canada, Mexico and China? Trump threatened a 25% tariff on imports from Mexico and Canada shortly after his election victory. Ten days after taking office, Trump went after the top three trading partners of the United States with an executive order imposing 25% tariffs on nearly all goods from Canada and Mexico. Trump said it was to force the countries to stem the flow of migrants and fentanyl across the United States border. Meanwhile, China was hit with a 10% tariff. Canada and Mexico immediately responded with retaliatory tariffs of their own. Two days later, Trump agreed to a 30-day pause. In March, Trump waived tariffs on goods compliant with the United State-Mexico-Canada Agreement (USMC) and the imposed 25% universal tariffs on steel, aluminum and automotive imports, including those from Mexico and Canada. Tariffs on steel, aluminum and copper were raised in June to 50% − Canada is the biggest supplier of steel and aluminum to the United States − while the tariffs on automotive imports held steady. Trump sent a letter to Canadian Prime Minister Mark Carney in July saying he planned to impose 35% tariffs across-the-board on imports from Canada come Aug. 1. Trump said fentanyl was "hardly the only" challenge United States had with Canada and that its trade barriers and non-tariff polices were causing "unsustainable" trade deficits. "Canada charges extraordinary Tariffs to our Dairy farmers – up to 400% - and that is even assuming our Dairy Farmers even have access to sell their products to the people of Canada," Trump said in the letter. In a letter to Mexican President Claudia Sheinbaum, Trump said that the country had helped in 'securing the border.' But he said Mexico had 'still not stopped the Cartels who are trying to turn all of North America into a Narco-Trafficking Playground.' After months of tit-for-tat tariffs and trade war with China, which saw the U.S. tariffs spiking to 145% and Chinese tariffs on U.S. goods reaching 125%, the two called a truce in May, agreeing to a 90-day suspension of the levies, set to expire on Aug 12. On June 11, Trump announced a deal had been 'done' subject to 'final approval' by both leaders. He said the U.S. tariffs would be set at 55% on imported Chinese goods while China's tariffs remain at 10%. Bessent, who is scheduled to meet his Chinese counterpart on July 28 in Stockholm, Sweden, indicated the deadline was likely to be moved. 'We'll be working out what is likely an extension' Bessent told Fox Business on July 22. Swapna Venugopal Ramaswamy is a White House correspondent for USA TODAY. You can follow her on X @SwapnaVenugopal
Business Wire
2 minutes ago
- Business Wire
Elation Survey Finds Nearly 40% of Primary Care Physicians Use AI-powered Tools for Daily Clinical Documentation
SAN FRANCISCO--(BUSINESS WIRE)-- Elation Health, the clinical-first technology company powering innovation in primary care, today announced the results of its latest AI in Primary Care survey of 291 primary care physicians, focused on the current sentiments, adoption patterns, critical concerns (defects), key behavioral insights (learnings), and explicit user desires (requests) regarding the integration of Artificial Intelligence (AI) in primary care workflows. The analysis reveals 39.3% use AI-powered tools daily, specifically for clinical documentation. The survey also revealed that clinicians have a clear hierarchy of needs when it comes to AI, with fundamental performance factors at the top of that hierarchy. With 59% of respondents in agreement, accuracy and reliability ranked as the most important factor when evaluating AI tools. Seamless workflow integration and ease of use followed at 22%, while efficiency and time savings (ROI) came in at 13%, and cost affordability at 6% (see Table 1). Table 1: Most Important Factors in Choosing an AI Tool 'Our survey confirms what we already suspected: clinicians are cautiously optimistic about AI's potential, but they're looking for thoughtful, trustworthy, affordable solutions that truly fit the realities of primary care,' said Sara Pastoor, MD, MHA, FAAFP, and director of primary care advancement for Elation Health. 'At Elation, we're applying AI in ways that are context-aware, and fit naturally into clinical and operational workflows to enable high-quality care hand in hand with long-term financial success.' While the survey also affirmed the general attitude towards AI in clinical settings is predominantly positive, a notable segment remains neutral or skeptical. Although a combined 59% of respondents rate their sentiment as "Positive" or "Very Positive," 24% of respondents were 'Neutral' in their sentiments about AI. This sizable group appears to be open to AI advancements but may be likely waiting for clear evidence of its value, reliability, and ease of use before fully embracing it. These findings reinforce how Elation approaches research and development with Elation's Innovation Labs that leverage a dynamic, interactive product development and testing framework to allow it to work shoulder-to-shoulder with clinicians and staff through design cycles, usability testing, and continuous in-product feedback. This ensures Elation is developing AI in ways that clinicians trust and find valuable. Elation Health's clinical-first approach to AI is distinguished by continuous, hands-on collaboration with primary care clinicians throughout the Elation Labs development process. Every new AI capability is shaped directly by clinician feedback, gathered through design cycles, usability testing, and ongoing in-product input. Elation's iterative, transparent partnership with customers ensures that its AI features are clinically relevant, trustworthy, and seamlessly integrated into daily workflows, empowering clinicians while keeping the focus firmly on patient care. The survey was conducted with 291 independent primary care clinicians who are current Elation Health customers. For more on the results from Elation's State of AI in Primary Care Clinical Practice survey, visit here. To join Elation's product developers for a live, interactive webinar to explore how ethical, clinician-designed AI embedded within the EHR is transforming primary care by reducing burnout, improving care quality, and empowering both clinicians and patients: register here. About Elation Elation Health is the clinical-first AI platform for primary care success. Trusted by over 36,000 clinicians and 20 million patients, Elation's EHR and billing solutions combine proven clinical workflows with responsible, predictive AI - purpose built for primary care. The company's clinical-first approach puts physicians at the center, delivering trusted, transparent innovation that saves time and sustains meaningful patient relationships. Elation Health is recognized as Best in KLAS for its commitment to excellence in primary care technology. Learn more at and on LinkedIn.
